Journal of Transgenics

Submit Manuscript
  • For authors
  • Open access ยท CC BY 4.0

Instructions for Authors

How to prepare and submit a manuscript to the Journal of Transgenics: submission routes, article types, manuscript structure, reporting standards, ethics statements and fees.

Submission

Submission routes

  1. Primary route

    ManuscriptZone

    The publisher's online submission and review system. Register or sign in, choose the Journal of Transgenics and upload the manuscript files.

  2. Alternative route

    Simple manuscript submission form

    A single-page form that opens with the Journal of Transgenics selected.

  3. Assisted route: editorial email

    info@openaccesspub.org

    For authors who are unable to use either online route. Send the manuscript files with a cover letter to the editorial office.

Authors must use only one submission route for the same manuscript.

Formats

Article types

JTR publishes the article types below. Requirements depend on the format; a Methods and Results structure applies where the design calls for it. The scope of each type is set out in the Aims and Scope.

Original Research

Empirical studies of transgenic organisms and genome editing, basic or applied, including studies that generate and characterize transgenic or genome-edited lines.

Abstract
Structured: Background, Methods, Results, Conclusions.
Main text
Introduction, Methods, Results, Discussion, Conclusions. State the research question and describe constructs, editing reagents, organisms or lines, controls and replication.
Reporting
The guideline for the design where one applies, for example ARRIVE 2.0 for animal research.

Review

Critical and balanced reviews of a defined topic in transgenics or genome editing. Systematic reviews state their methods.

Abstract
Unstructured, or structured for a systematic review.
Main text
Introduction; thematic sections that organize the literature; open questions and future directions. A systematic review gives its eligibility criteria, sources, search strategy and selection process.
Reporting
PRISMA 2020 for systematic reviews, where applicable.

Methods and Protocols

New, adapted or validated methods and step-by-step protocols for making, editing or characterizing transgenic organisms.

Abstract
Structured, with headings adapted to the method.
Main text
Rationale; a description of the method with the detail, materials, sequences and code others need to apply it; validation or a worked application, compared with existing approaches where available; limitations and troubleshooting.
Reporting
Provide construct sequences and reagent sources, and the guideline for the validation design where one applies.

Short Communication

A concise report of a focused or preliminary finding of clear importance to the field.

Abstract
Brief, structured.
Main text
A condensed Introduction, Methods, Results and Discussion centered on the main finding.
Reporting
As for Original Research, where applicable.

Data Note

A description of a dataset or resource of value to the field, such as sequence, expression or imaging data, to support its reuse.

Abstract
Brief, unstructured.
Main text
Background and rationale; data collection methods; description of the dataset (variables, format, coverage); quality control; data access, with the repository, persistent identifier and license; limitations for reuse. Analyses are limited to those that describe the data.
Reporting
Deposit the dataset in a recognized repository before submission, and follow the guideline for the original study design where applicable.

Commentary

An evidence-based argument on a current question in transgenics or genome editing, or on published research. Perspectives and viewpoints are submitted as Commentaries.

Abstract
None, or a brief unstructured summary.
Main text
A focused argument, supported by cited evidence, without a Methods and Results structure.
Reporting
Reference the evidence discussed.

Length. There are no fixed length limits for any article type; manuscripts should be concise and proportionate to their content.

Choosing a type. Where a manuscript sits between types, choose the closest type and explain the choice in the cover letter; the editors confirm the classification. A protocol is submitted as Methods and Protocols.

Manuscript

Preparing the manuscript

These requirements apply to every article type. The structure of the main text follows the guidance for the type above.

Files
The main text as an editable word-processing file (for example, Microsoft Word), with figures, tables that cannot be edited in the text, and supplementary material supplied as separate files.
Title page
A concise, informative title; full names, affiliations and ORCID iDs (recommended) of all authors; and the corresponding author's contact details.
Double-blind review
For double-blind review, remove author names, affiliations, acknowledgments, funding details, institution names, and other identifying information from the reviewer manuscript. Provide identifying information separately in the title-page file or submission form.
Abstract
As set for the article type. Structured abstracts use the headings Background, Methods, Results and Conclusions.
Keywords
A short list of specific, searchable terms.
Statistics and materials
Describe statistical methods in enough detail for replication; report sample sizes and replication, give exact p-values where statistical tests are used, and name the software and version.
Declarations
Author contributions (CRediT), funding, conflicts of interest, ethics approval and consent where applicable, data availability and any use of AI tools.
Cover letter
States the article type and the relevance of the work to transgenics or genome editing, confirms that the manuscript is not under consideration elsewhere, and notes any preprint and any request for double-blind review.
Language
Clear English, with abbreviations defined at first use.
Reporting standards

Reporting guidelines

Where a reporting guideline matches the design, report the study following it and upload the completed checklist as a supplementary file. The guidelines are available from the EQUATOR Network.

Reporting guidelines by study design
Study designGuideline
Animal researchARRIVE 2.0
Randomized trialsCONSORT
Observational studiesSTROBE
Systematic reviews and meta-analysesPRISMA 2020
Qualitative researchSRQR or COREQ
Presentation

References, tables and figures

Reference style
Numbered in order of first citation. List the first five authors, then et al., and give a DOI or stable URL where one exists. Authors are responsible for the accuracy of references.
Tables
Numbered consecutively, each with a descriptive title; abbreviations and symbols explained in a footnote.
Figures
High resolution (at least 300 dpi) in TIFF, EPS, PNG or high-quality JPEG, with a caption for each figure and text that remains legible after reduction. Maps state their data sources.
Supplementary files
Numbered (for example, Supplementary Table S1), cited in the text and listed with short titles at the end of the manuscript. They are published as supplied, so they must be final and free of participant identifiers.
Reused material
Written permission from the copyright holder to reproduce or adapt published figures, tables or text, unless the material is already available under a license that permits reuse; the source is cited in the legend.

Reference examples

Journal article
Author AA, Author BB, Author CC, Author DD, Author EE, et al. (Year) Title of the article. Journal Name. Volume(Issue):pages. DOI: 10.xxxx/xxxxx
Book
Author AA, Author BB (Year) Title of the Book. Edition. Place of publication: Publisher.
Report or webpage
Organization Name (Year) Title of the report or page. URL (accessed Month Day, Year)
Dataset
Author AA, Author BB (Year) Title of the dataset. Version. Repository Name. DOI or accession number
Preprint
Author AA, Author BB (Year) Title of the preprint. Preprint Server Name [Preprint]. DOI: 10.xxxx/xxxxx
Trial registration
Sponsor or Principal Investigator (Year) Title of the trial. Registry Name. Registration number. Registered Month Day, Year. URL
Research ethics

Ethics and declarations

Each manuscript includes the statements below that apply to it. The full policies are set out in the Editorial Policies.

  • Human participants or material

    Where the work involves human participants, identifiable data or human biological material, the name of the approving ethics committee or institutional review board, the approval reference number, and confirmation of informed consent, or a waiver documented by the ethics committee.

  • Biosafety and permits

    Where applicable, the biosafety committee approval and the permits for work with genetically modified organisms, including plants.

  • Animal research

    Approval from the institutional animal care and use committee or animal ethics committee with its reference number, compliance with animal-welfare regulations and the 3Rs, and reporting in line with the ARRIVE guidelines.

  • Constructs and sequences

    Sequences of constructs, guide RNAs and primers, and the source of plasmids and lines, so that the work can be repeated.

  • Conflicts of interest and funding

    All financial and non-financial interests of every author, each source of funding and the role of the funder.

  • Data availability

    Every empirical research manuscript must include a data-availability statement. It explains where the data can be found or the conditions for access.

  • Use of AI tools

    Any use of AI tools in writing, analysis or figure preparation, with the tool named and its use described. AI tools are not listed as authors.

After submission

Peer review and decisions

All submissions undergo initial editorial screening, including a similarity check with Crossref Similarity Check. Manuscripts that meet the journal's scope and minimum requirements proceed to independent peer review.

Single-blind by default; double-blind review is available on request.

Manuscripts that proceed to external peer review are normally evaluated by at least two independent subject-matter experts. Editorial decisions are based on scope, scientific quality, methodological rigor, ethical compliance, reporting quality, and relevance to the journal.

Revised manuscripts are accompanied by a point-by-point response to the reviewers' comments. After acceptance, authors check the proofs, and the article is published open access under CC BY 4.0.

Charges

Fees

USD 1,200 article processing charge for every article type.

The article processing charge is payable only after acceptance; withdrawal after submission is subject to the journal's withdrawal policy.

No charge is made at submission. Fee-relief inquiries are considered case by case; contact the editorial office before or at submission. Full details are on the Article Processing Charges page.

Before you submit

Final checklist

A fuller checklist and the submission routes are on the Submit Manuscript page.

  1. The manuscript concerns transgenic organisms or genome editing and uses one of the article types above.
  2. The title page, abstract, keywords and main text follow the guidance for the article type.
  3. For double-blind review, the reviewer manuscript is anonymized and identifying information is in the title-page file.
  4. Ethics approval, consent or waiver, and trial registration are reported where applicable.
  5. The completed reporting checklist is attached where applicable.
  6. Declarations cover contributions, funding, conflicts of interest, data availability and AI use.
  7. Figures, tables and supplementary files are cited in the text, and permissions are in place for reused material.
  8. A cover letter accompanies the submission, which is made through one route only.
Questions

Author inquiries

Questions about preparing or submitting a manuscript can be sent to the editorial office at info@openaccesspub.org.

Menu